Amarin Corp Plcuk (AMRN) Non-Current Deffered Revenue (2015 - 2024)

Amarin Corp Plcuk (AMRN) reported Non-Current Deffered Revenue of $2.1 million for Q1 2024, down 83.4% year-over-year from $12.7 million in Q2 2023, and down 15.98% quarter-over-quarter from $2.5 million in Q4 2023.

Amarin Corp Plcuk (AMRN) Non-Current Deffered Revenue (2015 - 2024) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 10 years of Non-Current Deffered Revenue data on file, last reported at $2.1 million in Q1 2024.

  • Non-Current Deffered Revenue for Q1 2024 came in at $2.1 million, down 83.4% year-over-year; the trailing twelve-month figure through Mar 2024 was $2.1 million (down 83.4% YoY), and the FY2023 annual result was $2.5 million, down 80.92% from the prior year.
  • Non-Current Deffered Revenue retreated to $2.1 million in Q1 2024 per AMRN's latest filing, from $2.5 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $17.5 million in Q1 2020 and troughed at $2.1 million in Q1 2024.
  • A 5-year average of $11.6 million and a median of $13.8 million in 2022 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2021 and 2024: Non-Current Deffered Revenue rose 9.75% in 2021, then plunged 83.4% in 2024.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $15.7 million in 2020, then dropped by 10.48% to $14.1 million in 2021, then declined by 6.49% to $13.1 million in 2022, then sank by 80.92% to $2.5 million in 2023, then declined by 15.98% to $2.1 million in 2024.
  • Business Quant data shows AMRN's Non-Current Deffered Revenue at $2.1 million in Q1 2024, $2.5 million in Q4 2023, and $2.9 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 2.11 Mn
Dec 31, 2023 2.51 Mn
Sep 30, 2023 2.95 Mn
Jun 30, 2023 3.33 Mn
Mar 31, 2023 12.70 Mn
Dec 31, 2022 13.15 Mn
Sep 30, 2022 13.50 Mn
Jun 30, 2022 13.81 Mn
Mar 31, 2022 14.14 Mn
Dec 31, 2021 14.06 Mn
Sep 30, 2021 14.49 Mn
Jun 30, 2021 14.83 Mn
Mar 31, 2021 15.20 Mn
Dec 31, 2020 15.71 Mn
Sep 30, 2020 13.20 Mn
Jun 30, 2020 14.51 Mn
Mar 31, 2020 17.52 Mn
Dec 31, 2019 18.50 Mn
Sep 30, 2019 17.62 Mn
Jun 30, 2019 17.78 Mn